BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 37009479)

  • 1. Transcription factors and potential therapeutic targets for pulmonary hypertension.
    Yang L; Wan N; Gong F; Wang X; Feng L; Liu G
    Front Cell Dev Biol; 2023; 11():1132060. PubMed ID: 37009479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of prostanoids, nitric oxide and endothelin pathways in pulmonary hypertension due to COPD.
    Alqarni AA; Aldhahir AM; Alghamdi SA; Alqahtani JS; Siraj RA; Alwafi H; AlGarni AA; Majrshi MS; Alshehri SM; Pang L
    Front Med (Lausanne); 2023; 10():1275684. PubMed ID: 37881627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Changes Implicate Angiogenesis and Arterial Remodeling in Systemic Sclerosis-Associated and Idiopathic Pulmonary Hypertension.
    Zhou Y; Tabib T; Huang M; Yuan K; Kim Y; Morse C; Sembrat J; Valenzi E; Lafyatis R
    Arterioscler Thromb Vasc Biol; 2024 Jun; ():. PubMed ID: 38841857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular mechanosignaling in pulmonary arterial hypertension.
    Wang A; Valdez-Jasso D
    Biophys Rev; 2021 Oct; 13(5):747-756. PubMed ID: 34765048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digital Spatial Profiling Identifies Distinct Molecular Signatures of Vascular Lesions in Pulmonary Arterial Hypertension.
    Tuder RM; Gandjeva A; Williams S; Kumar S; Kheyfets VO; Hatton-Jones KM; Starr JR; Yun J; Hong J; West NP; Stenmark KR
    Am J Respir Crit Care Med; 2024 Apr; ():. PubMed ID: 38568479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative Stress and Antioxidant Therapy in Pulmonary Hypertension.
    Poyatos P; Gratacós M; Samuel K; Orriols R; Tura-Ceide O
    Antioxidants (Basel); 2023 Apr; 12(5):. PubMed ID: 37237872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progenitor cells in pulmonary vascular remodeling.
    Yeager ME; Frid MG; Stenmark KR
    Pulm Circ; 2011; 1(1):3-16. PubMed ID: 22034593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unleashing the Potential of Nrf2: A Novel Therapeutic Target for Pulmonary Vascular Remodeling.
    Fang Q; Bai Y; Hu S; Ding J; Liu L; Dai M; Qiu J; Wu L; Rao X; Wang Y
    Antioxidants (Basel); 2023 Nov; 12(11):. PubMed ID: 38001831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unveiling the dual role of autophagy in vascular remodelling and its related diseases.
    Ren H; Dai R; Nik Nabil WN; Xi Z; Wang F; Xu H
    Biomed Pharmacother; 2023 Dec; 168():115643. PubMed ID: 37839111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelets, extracellular vesicles and coagulation in pulmonary arterial hypertension.
    Cullivan S; Murphy CA; Weiss L; Comer SP; Kevane B; McCullagh B; Maguire PB; Ní Ainle F; Gaine SP
    Pulm Circ; 2021; 11(3):20458940211021036. PubMed ID: 34158919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial Function in Pulmonary Arterial Hypertension: From Bench to Bedside.
    Correale M; Chirivì F; Bevere EML; Tricarico L; D'Alto M; Badagliacca R; Brunetti ND; Vizza CD; Ghio S
    J Clin Med; 2024 Apr; 13(8):. PubMed ID: 38673717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary Hypertension: Unveiling Molecular Mechanisms, Diagnosis, and Therapeutic Targets.
    Gredic M; Hadzic S
    J Pers Med; 2023 Sep; 13(10):. PubMed ID: 37888057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pulmonary (arterial) hypertension - clearly identify multiple clinical conditions].
    Dreher M
    Dtsch Med Wochenschr; 2023 Nov; 148(23):1477. PubMed ID: 37949075
    [No Abstract]   [Full Text] [Related]  

  • 14. New Therapeutic Target for Pulmonary Arterial Hypertension.
    Yoon KL
    Korean Circ J; 2018 Dec; 48(12):1145-1147. PubMed ID: 30403018
    [No Abstract]   [Full Text] [Related]  

  • 15. Pathophysiology and new advances in pulmonary hypertension.
    Bousseau S; Sobrano Fais R; Gu S; Frump A; Lahm T
    BMJ Med; 2023; 2(1):e000137. PubMed ID: 37051026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular regulation and therapeutic implications of cell death in pulmonary hypertension.
    Wang E; Zhou S; Zeng D; Wang R
    Cell Death Discov; 2023 Jul; 9(1):239. PubMed ID: 37438344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GATA6 coordinates cross-talk between BMP10 and oxidative stress axis in pulmonary arterial hypertension.
    Toyama T; Kudryashova TV; Ichihara A; Lenna S; Looney A; Shen Y; Jiang L; Teos L; Avolio T; Lin D; Kaplan U; Marden G; Dambal V; Goncharov D; Delisser H; Lafyatis R; Seta F; Goncharova EA; Trojanowska M
    Sci Rep; 2023 Apr; 13(1):6593. PubMed ID: 37087509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation and immunity in the pathogenesis of hypoxic pulmonary hypertension.
    Ye Y; Xu Q; Wuren T
    Front Immunol; 2023; 14():1162556. PubMed ID: 37215139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic reprogramming, oxidative stress, and pulmonary hypertension.
    Pokharel MD; Marciano DP; Fu P; Franco MC; Unwalla H; Tieu K; Fineman JR; Wang T; Black SM
    Redox Biol; 2023 Aug; 64():102797. PubMed ID: 37392518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of macrophages in pulmonary arterial hypertension.
    Zhang MQ; Wang CC; Pang XB; Shi JZ; Li HR; Xie XM; Wang Z; Zhang HD; Zhou YF; Chen JW; Han ZY; Zhao LL; He YY
    Front Immunol; 2023; 14():1152881. PubMed ID: 37153557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.